US Stock MarketDetailed Quotes
DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)
- 0.0086
- 0.00000.00%
Close Aug 30 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0086Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.029052wk High0.00P/B0Float Cap0.007052wk Low--Dividend TTM0Shs Float1.7000Historical High--Div YieldTTM0.00%Amplitude0.0050Historical Low--Avg Price1Lot Size
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -15.52%-2.13M | -63.94%-2.7M | 27.45%-6.41M | 37.15%-1.15M | 30.83%-1.77M | -0.05%-1.84M | 36.74%-1.65M | -55.17%-8.83M | -1.20%-1.83M | -15.89%-2.56M |
| Net income from continuing operations | -66.28%-2.83M | -39.91%-3.13M | 18.90%-7.79M | -27.81%-2.13M | 29.09%-1.72M | 37.69%-1.7M | 19.60%-2.24M | -21.62%-9.61M | 34.60%-1.67M | -41.55%-2.42M |
| Change In working capital | 353.00%683.55K | -134.28%-157.43K | 662.38%863.68K | 327.75%858.2K | 50.60%-183.59K | -142.92%-270.18K | 1,428.23%459.25K | -153.04%-153.58K | -244.80%-376.82K | 41.92%-371.67K |
| -Change in prepaid assets | 7.63%273.38K | -46.00%94.42K | 33.42%162.7K | -26.10%151.4K | 18.05%-417.55K | -44.12%254K | 726.18%174.85K | 116.26%121.94K | -20.38%204.87K | -36.68%-509.52K |
| -Change in payables and accrued expense | 178.25%410.17K | -188.55%-251.85K | 354.43%700.98K | 221.51%706.8K | 69.71%233.96K | -399.58%-524.17K | 4,374.78%284.4K | -126.50%-275.52K | -20,034.51%-581.69K | 151.60%137.85K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -15.52%-2.13M | -63.94%-2.7M | 27.45%-6.41M | 37.15%-1.15M | 30.83%-1.77M | -0.05%-1.84M | 36.74%-1.65M | -55.17%-8.83M | -1.20%-1.83M | -15.89%-2.56M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 54.71%2.34M | 0 | 77.84%7.61M | 1.95M | -17,809.50%-35.42K | -64.64%1.51M | 4.18M | -73.21%4.28M | 0 | -100.00%200 |
| Net common stock issuance | 59.34%2.41M | --0 | 77.85%7.61M | --1.95M | ---35.42K | -64.64%1.51M | --4.17M | -72.21%4.28M | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | -34.84%187 | --0 | --0 | -60.92%34 | --153 | --287 | --0 | --200 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 54.71%2.34M | --0 | 77.84%7.61M | --1.95M | -17,809.50%-35.42K | -64.64%1.51M | --4.18M | -73.21%4.28M | --0 | -100.00%200 |
| Net cash flow | ||||||||||
| Beginning cash position | -46.00%4.73M | 19.18%7.44M | -42.20%6.24M | -17.79%6.63M | -20.60%8.44M | 7.03%8.77M | -42.20%6.24M | 1,935.97%10.8M | -35.99%8.07M | 2,387.79%10.63M |
| Current changes in cash | 165.02%213.42K | -207.09%-2.7M | 126.26%1.2M | 144.19%806.65K | 29.44%-1.81M | -113.47%-328.23K | 196.84%2.53M | -144.38%-4.56M | -1.16%-1.83M | -121.03%-2.56M |
| End cash Position | -41.37%4.95M | -46.00%4.73M | 19.18%7.44M | 19.18%7.44M | -17.79%6.63M | -20.60%8.44M | 7.03%8.77M | -42.20%6.24M | -42.20%6.24M | -35.99%8.07M |
| Free cash flow | -15.52%-2.13M | -63.94%-2.7M | 27.45%-6.41M | 37.15%-1.15M | 30.83%-1.77M | -0.05%-1.84M | 36.74%-1.65M | -55.17%-8.83M | -1.20%-1.83M | -15.89%-2.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg